Resultados de búsqueda - Kjetil Tasken

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors. por Nora V Lieske, Kristian Tonby, Dag Kvale, Anne M Dyrhol-Riise, Kjetil Tasken

Enlace del recurso

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare por Elisa Bjørgo, Gro L. Fagereng, Hege G. Russnes, Sigbjørn Smeland, Kjetil Taskén, Åslaug Helland

Enlace del recurso

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection por Kristian Tonby, Ida Wergeland, Nora V. Lieske, Dag Kvale, Kjetil Tasken, Anne M. Dyrhol-Riise

Enlace del recurso

Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders por Kristina Berg Lorvik, Kristina Berg Lorvik, Kristina Berg Lorvik, Malin Holm Meyer-Myklestad, Malin Holm Meyer-Myklestad, Kushi Kushekar, Kushi Kushekar, Charlotte Handeland, Asle Wilhelm Medhus, Marius Lund-Iversen, Birgitte Stiksrud, Dag Kvale, Dag Kvale, Anne Margarita Dyrhol-Riise, Anne Margarita Dyrhol-Riise, Kjetil Taskén, Kjetil Taskén, Kjetil Taskén, Dag Henrik Reikvam, Dag Henrik Reikvam

Enlace del recurso

Merging clinical research and standard healthcare – Nordic Precision Cancer Medicine Symposium 2025 por Elisa Bjørgo, Nina Ånensen, Gro Live Fagereng, Hege G. Russnes, Sigbjørn Smeland, Kjetil Taskén, Åslaug Helland

Enlace del recurso

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients por Marthe Jøntvedt Jørgensen, Marthe Jøntvedt Jørgensen, Kristin G. Nore, Hans Christian D. Aass, Emilie Layre, Jérôme Nigou, Rasmus Mortensen, Kjetil Tasken, Kjetil Tasken, Dag Kvale, Synne Jenum, Kristian Tonby, Kristian Tonby, Anne Ma Dyrhol-Riise, Anne Ma Dyrhol-Riise

Enlace del recurso

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity por Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van derVeen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén

Enlace del recurso

A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target–driven treatment regimens in oncology por Oskar Frisell, Eline Aas, Pia Sofie Henkel, Gro Live Fagereng, Kjetil Taskén, Ebba Hallersjö Hult, Peter Lindgren, Katarina Steen Carlsson

Enlace del recurso

Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways por Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise‐Lotte Flage‐Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén

Enlace del recurso

Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells por Anna Parente-Ribes, Sigrid S. Skånland, Simone Bürgler, Audun Os, Dong Wang, Bjarne Bogen, Geir E. Tjønnfjord, Kjetil Taskén, Ludvig A. Munthe

Enlace del recurso

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial. por Christian Prebensen, Marius Trøseid, Thor Ueland, Anders Dahm, Per Morten Sandset, Ingeborg Aaberge, Kristian Waalen, Anne Ma Dyrhol-Riise, Kjetil Taskén, Dag Kvale

Enlace del recurso

Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically por Mariaserena Giliberto, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Sigrid S. Skånland, Alexandra Gade, Geir E. Tjønnfjord, Fredrik Schjesvold, Ludvig A. Munthe, Kjetil Taskén

Enlace del recurso

Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnostics por Pia S. Henkel, Kine Pedersen, Kjetil Taskén, Ebba Hallersjö Hult, Hans Gelderblom, G. Live Fagereng, Helga B. Landsverk, Eline Aas, on behalf of the PCM4EU consortium partners

Enlace del recurso

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies por Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Sigrid S. Skånland

Enlace del recurso

‘Crossing borders’ in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine por Maria Martin Agudo, Henk van der Pol, Gabriel Bratseth Stav, Tina Kringelbach, Katarina Puco, Åsmund Flobak, Hans Gelderblom, Kjetil Taskén, Gro Live Fagereng, Eivind Hovig

Enlace del recurso

C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. por Johannes Landskron, Sigrid M Kraggerud, Elisabeth Wik, Anne Dørum, Merete Bjørnslett, Espen Melum, Øystein Helland, Line Bjørge, Ragnhild A Lothe, Helga B Salvesen, Kjetil Taskén

Enlace del recurso

A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine por Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord, Sigrid S. Skånland

Enlace del recurso

P613: ANALYSIS OF EX-VIVO RESPONSE TO SINGLE DRUGS AND DRUG COMBINATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT SAMPLES por Leonardo Miranda Santana, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Mariaserena Giliberto, Alexandra Gade, Arnoldo Frigessi, Geir E. Tjønnfjord, Ludvig A. Munthe, Sigrid S. Skånland, Manuela Zucknick, Kjetil Taskén

Enlace del recurso

Sensing of HIV-1 by TLR8 activates human T cells and reverses latency por Hany Zekaria Meås, Markus Haug, Marianne Sandvold Beckwith, Claire Louet, Liv Ryan, Zhenyi Hu, Johannes Landskron, Svein Arne Nordbø, Kjetil Taskén, Hang Yin, Jan Kristian Damås, Trude Helen Flo

Enlace del recurso

Standardized assays to monitor drug sensitivity in hematologic cancers por Pilar Ayuda-Durán, Johanne U. Hermansen, Mariaserena Giliberto, Yanping Yin, Robert Hanes, Sandra Gordon, Heikki Kuusanmäki, Andrea M. Brodersen, Aram N. Andersen, Kjetil Taskén, Krister Wennerberg, Jorrit M. Enserink, Sigrid S. Skånland

Enlace del recurso